Zepp Health (ZEPP) Current Deferred Revenue (2016 - 2026)

Zepp Health has reported Current Deferred Revenue for 11 years, with the latest figure at $56000.0 in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 77.6% year-over-year to $56000.0 in Q2 2026; TTM through Jun 2026 was $56000.0, a 77.6% decrease from a year earlier, with the FY2025 full-year figure at $76000.0, down 61.42% from the prior year.
• Current Deferred Revenue was $56000.0 for Q2 2026 at Zepp Health, up from $43000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $537000.0 in Q2 2023, with the low at $43000.0 in Q1 2026.
• Average Current Deferred Revenue over 5 years is $248305.0, with a median of $243500.0 recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue tumbled 95.55% in 2022, then soared 58.88% in 2023.
• Over 5 years, Current Deferred Revenue stood at $299908.5 in 2022, then slipped by 23.45% to $229580.9 in 2023, then slipped by 14.19% to $197000.0 in 2024, then slumped by 61.42% to $76000.0 in 2025, then retreated by 26.32% to $56000.0 in 2026.
• The last three Current Deferred Revenue figures came in at $56000.0 (Q2 2026), $43000.0 (Q1 2026), and $76000.0 (Q4 2025), per Business Quant data.